# Safety and Efficacy Placebo Controlled Study of ATH008 Cream in PPES Patients Secondary to Capecitabine

> **NCT01316406** · PHASE2 · COMPLETED · sponsor: **Advancell - Advanced In Vitro Cell Technologies, S.A.** · enrollment: 122 (actual)

## Conditions studied

- Palmar-Plantar Erythrodysesthesia Syndrome

## Interventions

- **DRUG:** ATH008

## Key facts

- **NCT ID:** NCT01316406
- **Lead sponsor:** Advancell - Advanced In Vitro Cell Technologies, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2014-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01316406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01316406, "Safety and Efficacy Placebo Controlled Study of ATH008 Cream in PPES Patients Secondary to Capecitabine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01316406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*